These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 16911518

  • 1. Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin.
    Mitsui S, Nakamura T, Okui A, Kominami K, Uemura H, Yamaguchi N.
    FEBS J; 2006 Aug; 273(16):3678-86. PubMed ID: 16911518
    [Abstract] [Full Text] [Related]

  • 2. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX, Searcy TR, Wu Y, Gozal D, Wang Y.
    Physiol Genomics; 2007 Dec 19; 32(1):95-104. PubMed ID: 17911380
    [Abstract] [Full Text] [Related]

  • 3. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters.
    Chen J, Randeva HS.
    Biochem J; 2010 Apr 14; 427(3):377-90. PubMed ID: 20156195
    [Abstract] [Full Text] [Related]

  • 4. Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate.
    Nakamura T, Mitsui S, Okui A, Miki T, Yamaguchi N.
    Prostate; 2003 Mar 01; 54(4):299-305. PubMed ID: 12539228
    [Abstract] [Full Text] [Related]

  • 5. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H, Takizawa T, Takamori K, Ogawa H, Araki Y.
    Mol Reprod Dev; 2007 Feb 01; 74(2):154-62. PubMed ID: 16941676
    [Abstract] [Full Text] [Related]

  • 6. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
    Vitale L, Frabetti F, Huntsman SA, Canaider S, Casadei R, Lenzi L, Facchin F, Carinci P, Zannotti M, Coppola D, Strippoli P.
    BMC Cancer; 2007 Apr 18; 7():66. PubMed ID: 17442112
    [Abstract] [Full Text] [Related]

  • 7. Tissue-specific N-terminal isoforms from overlapping alternate promoters of the human AE2 anion exchanger gene.
    Medina JF, Lecanda J, Acín A, Ciesielczyk P, Prieto J.
    Biochem Biophys Res Commun; 2000 Jan 07; 267(1):228-35. PubMed ID: 10623603
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue.
    Scheepers A, Schmidt S, Manolescu A, Cheeseman CI, Bell A, Zahn C, Joost HG, Schürmann A.
    Mol Membr Biol; 2005 Jan 07; 22(4):339-51. PubMed ID: 16154905
    [Abstract] [Full Text] [Related]

  • 9. A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate.
    Mitsui S, Yamada T, Okui A, Kominami K, Uemura H, Yamaguchi N.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):205-11. PubMed ID: 10872828
    [Abstract] [Full Text] [Related]

  • 10. Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters.
    Lin CS, Chow S, Lau A, Tu R, Lue TF.
    Int J Impot Res; 2002 Feb 27; 14(1):15-24. PubMed ID: 11896473
    [Abstract] [Full Text] [Related]

  • 11. Alternative usage of 5' exons in the chicken nerve growth factor gene: refined characterization of a weakly expressed gene.
    Bertaux O, Toselli-Mollereau E, Auffray C, Devignes MD.
    Gene; 2004 Jun 09; 334():83-97. PubMed ID: 15256258
    [Abstract] [Full Text] [Related]

  • 12. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
    Weng J, Ma W, Mitchell D, Zhang J, Liu M.
    J Cell Biochem; 2005 Dec 01; 96(5):1034-48. PubMed ID: 16149059
    [Abstract] [Full Text] [Related]

  • 13. Characterization of human deoxyribonuclease I gene (DNASE1) promoters reveals the utilization of two transcription-starting exons and the involvement of Sp1 in its transcriptional regulation.
    Kominato Y, Ueki M, Iida R, Kawai Y, Nakajima T, Makita C, Itoi M, Tajima Y, Kishi K, Yasuda T.
    FEBS J; 2006 Jul 01; 273(13):3094-105. PubMed ID: 16771825
    [Abstract] [Full Text] [Related]

  • 14. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
    Raevskaya NM, Dergunova LV, Vladychenskaya IP, Stavchansky VV, Oborina MV, Poltaraus AB, Limborska SA.
    Gene; 2005 Oct 10; 359():127-37. PubMed ID: 16162394
    [Abstract] [Full Text] [Related]

  • 15. Alternative splicing and nonsense-mediated mRNA decay regulate gene expression of serum response factor.
    Zhang X, Azhar G, Huang C, Cui C, Zhong Y, Huck S, Wei JY.
    Gene; 2007 Oct 01; 400(1-2):131-9. PubMed ID: 17629633
    [Abstract] [Full Text] [Related]

  • 16. Three distinct promoters direct transcription of different 5' untranslated regions of the human interleukin 1 type I receptor: a possible mechanism for control of translation.
    Ye K, Vannier E, Clark BD, Sims JE, Dinarello CA.
    Cytokine; 1996 Jun 01; 8(6):421-9. PubMed ID: 8818538
    [Abstract] [Full Text] [Related]

  • 17. Cloning and expression of ligand-gated ion-channel receptor L2 in central nervous system.
    Houtani T, Munemoto Y, Kase M, Sakuma S, Tsutsumi T, Sugimoto T.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):277-85. PubMed ID: 16083862
    [Abstract] [Full Text] [Related]

  • 18. Isolation and functional analysis of alternative promoters in the human aquaporin-4 water channel gene.
    Umenishi F, Verkman AS.
    Genomics; 1998 Jun 15; 50(3):373-7. PubMed ID: 9676432
    [Abstract] [Full Text] [Related]

  • 19. Multiple transcription initiation and alternative splicing in the 5' untranslated region of the core 2 beta1-6 N-acetylglucosaminyltransferase I gene.
    Falkenberg VR, Alvarez K, Roman C, Fregien N.
    Glycobiology; 2003 Jun 15; 13(6):411-8. PubMed ID: 12626388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.